MENU
LIXT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Lixte Biotechnology Holdings (LIXT) Ownership - Who owns Lixte Biotechnology Holdings?

Lixte Biotechnology Holdings Inc is a clinical-stage biopharmaceutical and proton cancer therapy company focused on identifying new targets for cancer drug development and developing and commercializing cancer therapies... Show more

Profile

Industry
N/A
Address
433 Plaza Real
Phone
+1 631 830-7092
Employees
3
Web
https://www.lixte.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
107.62M
P/E Ratio
N/A
Total Cash
3.25M
Projected Growth
N/A
Total Debt
595.42K
Revenue
N/A
Risk (Beta)
1.59
Dividend Yield
N/A
Total Cash/Share
0.19
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
LIXT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
433 Plaza Real
Phone
+1 631 830-7092
Employees
3
Web
https://www.lixte.com